Anavex Life Sciences Corp. Detailed Financials

Full historical quarterly statements

Metric2025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Total Revenue00000000
Cost of Goods Sold00000000
Gross Profit00000000
R&D Expenses4.7M7.3M10.0M9.9M10.4M11.6M11.8M9.7M
Operating Expenses6.8M10.8M14.5M12.5M13.6M14.3M14.6M12.6M
Operating Income-6.8M-10.8M-14.5M-12.5M-13.6M-14.3M-14.6M-12.6M
Other Income / Gains1.1M1.0M1.2M1.3M1.5M2.6M2.4M2.1M
Net Income-5.7M-9.8M-13.2M-11.2M-12.1M-11.6M-12.2M-10.5M
EPS (Diluted)-0.064-0.11-0.16-0.13-0.14-0.14-0.14-0.13
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses2.1M3.5M4.5M2.6M3.1M2.8M2.8M2.9M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses2.1M3.5M4.5M2.6M3.1M2.8M2.8M2.9M
Other Expenses00000000
Cost And Expenses6.8M10.8M14.5M12.5M13.6M14.3M14.6M12.6M
Interest Income1.1M999K1.1M1.2M1.4M1.8M1.8M1.8M
Interest Expense00000000
Depreciation And Amortization00000000
Ebitda-5.7M-6.5M-14.3M-12.4M-13.6M-11.7M-14.1M-12.2M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-5.7M-9.8M-13.2M-11.2M-12.1M-11.7M-12.2M-10.5M
Income Before Tax Ratio00000000
Income Tax Expense18K0000-124K00
Net Income Ratio00000000
Epsdiluted-0.064-0.11-0.16-0.13-0.14-0.14-0.14-0.13
Weighted Average Shs Out89.0M85.9M85.4M85.1M84.8M84.0M84.5M82.5M
Weighted Average Shs Out Dil89.0M85.9M85.4M85.1M84.8M84.0M84.5M82.5M